The Harms of Over-Testing and Overdiagnosis

A test done on a person who feels well can leave them worse off, because the wider you look for disease in symptom-free people, the more false alarms and chance findings you turn up, and each one can pull you into procedures that carry real risk. Over-testing is not a failure of caution. It is the predictable result of using powerful tests on populations who were never likely to benefit, and its main downstream product is overdiagnosis: labelling and treating disease that would never have caused harm.

Why more testing is not automatically safer

The intuition that an extra test can only help is wrong in a specific, mathematical way. No test is perfect, so a small share of healthy people will get an abnormal result by chance. When you test millions of people who feel fine, even a low false-alarm rate produces a large absolute number of people sent for follow-up, most of whom turn out to have nothing wrong ¹. The net you cast catches a few real cases and a great deal of noise.

This is why a screening test earns its place only when the condition is common enough, serious enough, detectable early, and treatable more effectively when caught early, with a test that is accurate and acceptable. Those long-standing criteria exist precisely to keep tests away from situations where the harms outweigh the benefits ². A test that is excellent at confirming disease in a sick person can be a poor screening tool in a well one.

False positives, false alarms, and the cascade

A false positive is an abnormal result that further testing shows to be nothing. These are not rare. Across years of repeat mammography, for example, a large proportion of women will be recalled at least once for extra imaging or a biopsy that finds no cancer ³. The result is anxiety, time off work, and sometimes physical harm from the follow-up itself.

The deeper problem is the cascade. One borderline number prompts a repeat test, which prompts a scan, which finds a second incidental thing, which prompts a biopsy. Each step feels reasonable in isolation, yet the chain as a whole can carry more risk than the original concern justified ⁴. When you weigh a test, the honest question is not “is this test safe?” but “what is everything this result could set in motion?”

Overdiagnosis: real disease, no benefit from finding it

Overdiagnosis is subtler than a false positive and arguably more important. It means detecting a disease that is genuinely present under the microscope but would never have grown enough to cause symptoms or shorten life. Because clinicians usually cannot tell in advance which screen-detected cases are harmless, overdiagnosis leads to surgery, radiation, or long-term medication that brings risk without benefit.

It shows up across many areas: small thyroid cancers found incidentally, slow-growing prostate cancers, and ductal carcinoma in situ found on mammography, some of which would never have progressed. Overdiagnosis is one of the main reasons screening recommendations are specific to age and risk groups rather than offered to everyone ³. Good programmes count and publish their overdiagnosis estimates rather than hide them, and good decision aids place that number next to the benefit so the choice is informed.

Incidental findings: the unplanned discovery

Modern imaging is so sensitive that scans routinely reveal things no one was looking for. These incidental findings, sometimes called incidentalomas, are small nodules or spots on the thyroid, adrenal glands, lungs, or kidneys, found by chance during a scan ordered for another reason. Most are harmless. The trouble is that a single scan often cannot prove this, so it triggers repeat imaging or a biopsy purely to rule out the small chance that the spot matters.

This is the central argument against whole-body scans and broad “executive” or private screening packages marketed to people without symptoms. Major evidence bodies do not generally recommend them: they frequently surface incidentalomas of uncertain meaning and have not been shown to help healthy people live longer ⁴. Costs vary by country and health system, but the more relevant price is the procedures and worry the findings generate.

How to test enough, but not too much

The protective approach is risk-based, not maximal. It weighs your age, sex, family history, and personal risk factors against the benefits and harms of each test, follows recommended intervals rather than testing constantly, and is decided with a clinician who knows your history. Take up the screens you are eligible for, such as cervical, breast, and colorectal screening in the right age windows, and treat broad testing of symptom-free people with healthy skepticism.

Two habits help in practice. First, before agreeing to any test, ask what a positive result would lead to and how often the test raises a false alarm; if the answer is a chain of further procedures for a low underlying risk, that is a reason to pause. Second, keep symptom awareness separate from screening: a new or persistent symptom deserves assessment regardless of when you were last screened, and that is a different decision from adding routine tests you do not need ⁵. More information is only an advantage when it changes a decision for the better.

This article is general information, not medical advice. Discuss your own testing and screening choices with a qualified clinician who knows your history.